These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10718366)

  • 21. [Establishment and characterization of a tumor marker producing cell line (JR-1) derived from a gastric scirrhous cancer].
    Terano A; Nakada R; Mutoh H; Hiraishi H; Ota S; Kimura K; Aoyama H; Sugimoto T; Shiga J; Itoh Y
    Hum Cell; 1989 Sep; 2(3):307-9. PubMed ID: 2562403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
    Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
    Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.
    Saijyo S; Kudo T; Suzuki M; Katayose Y; Shinoda M; Muto T; Fukuhara K; Suzuki T; Matsuno S
    Tohoku J Exp Med; 1995 Sep; 177(1):61-71. PubMed ID: 8693487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.
    Rattanasinganchan P; Leelawat K; Treepongkaruna SA; Tocharoentanaphol C; Subwongcharoen S; Suthiphongchai T; Tohtong R
    World J Gastroenterol; 2006 Oct; 12(40):6500-6. PubMed ID: 17072981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
    Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
    Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma.
    Lucarotti ME; Habib NA; Kelly SB; Rothnie ND; Nelson O; Lindholm L; Cooper MJ; Wood CB; Williamson RC
    Eur J Surg Oncol; 1991 Feb; 17(1):51-3. PubMed ID: 1995358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment and characterization of human cholaginocarcinoma, MEC, producing carbohydrate antigen 19-9].
    Yoshida K; Tomizawa H; Ota T; Nagashima T; Kikuchi H; Watanabe H; Hashizaki K; Yonaha A
    Hum Cell; 1990 Dec; 3(4):346-51. PubMed ID: 1965684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.
    Luang S; Teeravirote K; Saentaweesuk W; Ma-In P; Silsirivanit A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207685
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular carcinoma producing carcinoembryonic antigen and carbohydrate antigen 19-9.
    Usui Y; Miura H; Kimura Y; Takayama S; Nakayama M
    Intern Med; 1992 Jun; 31(6):791-3. PubMed ID: 1327309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
    Li YG; Zhang N
    Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
    Cavalloni G; Peraldo-Neia C; Varamo C; Casorzo L; Dell'Aglio C; Bernabei P; Chiorino G; Aglietta M; Leone F
    Tumour Biol; 2016 Mar; 37(3):4041-52. PubMed ID: 26486326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model.
    Yamada N; Chung YS; Arimoto Y; Sawada T; Seki S; Sowa M
    Br J Cancer; 1995 Mar; 71(3):543-8. PubMed ID: 7880737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
    Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
    Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.
    Tshering G; Dorji PW; Chaijaroenkul W; Na-Bangchang K
    Am J Trop Med Hyg; 2018 Jun; 98(6):1788-1797. PubMed ID: 29637880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adenocarcinoma of the bladder producing carcinoembryonic antigen and carbohydrate antigen 19-9: report of a case].
    Iwaki H; Omatsu S; Konishi T; Moritani S
    Hinyokika Kiyo; 1997 May; 43(5):355-8. PubMed ID: 9208321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.